Dr. Patrick Judson

Hematology
460 N Reading Rd, Wellspan Medical Oncology, 
Ephrata, PA 
Clinical Trials:Currently Recruiting for 1 Trial
460 N Reading Rd, Wellspan Medical Oncology, 
Ephrata, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Patrick Judson is a Hematologist in Ephrata, Pennsylvania. Dr. Judson is rated as an Experienced provider by MediFind in the treatment of Testicular Yolk Sac Tumor. His top areas of expertise are Thrombocytopenia, ALK-Positive Non-Small Cell Lung Cancer, Richter Syndrome, and Chronic B-Cell Leukemia (CBCL).

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Licenses
Internal Medicine in PA
Hospital Affiliations
Wellspan Good Samaritan Hospital
Wellspan York Hospital
Lancaster General Hospital
Wellspan Ephrata Community Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

GOOD SAMARITAN PHYSICIAN SERVICES
460 N Reading Rd, Wellspan Medical Oncology, Ephrata, PA 17522

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
Enrollment Status: Recruiting
Publish Date: December 05, 2025
Intervention Type: Drug
Study Drug: Screening Platform
Study Phase: Phase 2/Phase 3
A Phase II Study of Rucaparib in Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
A Phase II Study of Rucaparib in Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Sub-Study)
Enrollment Status: Completed
Publish Date: May 21, 2025
Intervention Type: Drug
Study Drug: Rucaparib
Study Phase: Phase 2
Evaluation of Mammographic Breast Density Effect of Aspirin: a Companion Study to Alliance Study A011502
Evaluation of Mammographic Breast Density Effect of Aspirin: a Companion Study to Alliance Study A011502
Enrollment Status: Terminated
Publish Date: January 16, 2025
Intervention Type: Procedure
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated With Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug, Biological
Study Drugs: Docetaxel, Gemcitabine, Gemcitabine Hydrochloride, Pembrolizumab, Pemetrexed, Pemetrexed Disodium, Ramucirumab
Study Phase: Phase 2
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Distinguished in Testicular Yolk Sac Tumor
Dr. Meher Burki
Hematology | Oncology
Distinguished in Testicular Yolk Sac Tumor
Dr. Meher Burki
Hematology | Oncology

Abramson Cancer Center Kennett Square

400 McFarlan Road, Suite 300, 
Kennett Square, PA 
 (34.5 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Meher Burki is a Hematologist and an Oncologist in Kennett Square, Pennsylvania. Dr. Burki is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. Her top areas of expertise are Paget Disease of the Breast, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, and Bone Marrow Aspiration. Dr. Burki is currently accepting new patients.

Distinguished in Testicular Yolk Sac Tumor
Dr. Paul Celano
Oncology | Hematology
Distinguished in Testicular Yolk Sac Tumor
Dr. Paul Celano
Oncology | Hematology

Greater Baltimore Medical Center Inc

6715 N Charles St, 
Baltimore, MD 
 (60.6 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Paul Celano is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Celano is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. His top areas of expertise are Ovarian Cancer, Testicular Yolk Sac Tumor, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma.

Distinguished in Testicular Yolk Sac Tumor
Dr. William E. Luginbuhl
Hematology | Oncology
Distinguished in Testicular Yolk Sac Tumor
Dr. William E. Luginbuhl
Hematology | Oncology

Abramson Cancer Center Kennett Square

400 McFarlan Road, Suite 300, 
Kennett Square, PA 
 (34.5 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances

William Luginbuhl is a Hematologist and an Oncologist in Kennett Square, Pennsylvania. Dr. Luginbuhl is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Colorectal Cancer, and Lynch Syndrome.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Judson's expertise for a condition
ConditionClose
      View All 43 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile